Alerte De Sécurité sur Commercial Name: Revascularization Device Mindframe Capture LP. Technical Name: Clot Removal Device. ANVISA registration number: 10349000580. Risk class: IV. Affected model: 300010; 300011; 300012; 300013. Serial number affected: A568589; A560811; A544383

Selon Agência Nacional de Vigilância Sanitária (ANVISA), ce/cet/cette alerte de sécurité concerne un dispositif en/au/aux/à Brazil qui a été fabriqué par Auto Suture do Brasil Ltda; Micro Therapeutics, Inc, d/b/a ev3 Neurovascular.

Qu'est-ce que c'est?

Les alertes fournissent des informations importantes et des recommandations concernant les dispositifs médicaux. Le fait qu'une alerte soit émise ne signifie pas nécessairement qu'un dispositif soit dangereux. Les alertes de sécurité, qui sont envoyées tant aux travailleurs du secteur médical qu'aux utilisateurs de ces dispositifs, peuvent inclure des rappels. Elles peuvent être rédigées par des fabricants mais aussi par des autorités en charge de la santé.

En savoir plus sur les données ici
  • Type d'événement
    Safety alert
  • ID de l'événement
  • Date
  • Pays de l'événement
  • Source de l'événement
  • URL de la source de l'événement
  • Notes / Alertes
    Brazilian data is current through June 2018. All of the data comes from Anvisa, except for the categories Manufacturer Parent Company and Product Classification.
    The Parent Company and the Product Classification were added by ICIJ.
    The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of data from the U.S. and Brazil.
  • Notes supplémentaires dans les données
    For the affected product that has not been used, Medtronic requests immediate action. 1. Remove and quarantine all unused products in your inventory. 2. Return the affected products to the Auto Suture (PLC). Your representative can help facilitate the return of the product as needed. 3. Complete the Customer Confirmation Form, and return it to the Auto Suture (PLC). If you wish to notify technical complaints and adverse events use the following channels: Notivisa: Notices of adverse events (AE) and technical complaints (QT) for products subject to Sanitary Surveillance should be made through the NOTIVISA System. To access the System, you must register and select the Health Professional option, if you are a liberal professional or the Institution / Entity option, if you are a professional of an institution / entity. Technovigilance System: Patient or citizen can notify through the Technovigilance System / SISTEC access through the link Additional information: - Date of identification of the problem by the company: 01/03/2018 - Date of notification notice for Anvisa: 08/03/2018 The company that owns the affected product is responsible for contacting its customers in due time. to ensure the effectiveness of the Field Action in progress. It stands out the joint responsibility of the distribution chain and use of health products in maintaining its quality, safety and efficacy, as well as the effectiveness of the Field Action, expressed by RDC 23/2012: "(...) Art 2 ° A holder of registration of health product is the holder of the registration / registration of health product with Anvisa. Single paragraph. The registration holder, as well as other agents involved from the production to the use of the product, or discarding it when applicable, are jointly and severally responsible for maintaining the quality, safety and efficacy of the health products to the final consumer. Art. 12 Distributors of health products shall forward to the registration holder, in a timely manner, the distribution map and other information requested for the notification and execution of field actions. (...) "
  • Cause
    Partial detachment or separation of the mindframe capture tm lp device may lead to vessel damage or the foreign body of the device may clog the bloodstream. potential complications or irreversible damage associated with this problem include, but are not limited to: prolonged procedure, incomplete treatment, internal damage, vasospasm, dissection, intracranial hemorrhagic, hematoma, transient ischemic attack, ischemic stroke / cerebral infarction, neurological deficit, and / or death. until february 23, 2018, auto suture (medtronic plc) has received a total of twenty (20) partial release or separation reports from the mindframe capturetm lp device. there were a total of three (3) reported serious damage reports, which include two (2) death reports potentially associated with this problem, we also report that these reports occurred outside brazil.
  • Action
    Field Action Code FA804 triggered under the responsibility of the company Auto Suture do Brasil Ltda. It will make recollection.


  • Société-mère du fabricant (2017)
  • Commentaire du fabricant
    “If our surveillance systems identify a potential performance issue, our personnel promptly evaluate the problem, including, when appropriate, conducting root cause investigations and internal testing to assess whether the product continues to meet specifications and defined performance criteria,” Medtronic told ICIJ in a statement. “In some cases, based on this evaluation, Medtronic may determine that a recall is necessary.” The company said that it communicates with healthcare providers and/or patients and provide recommendations to address such issues. Medtronic noted that these communications can include letters, emails, calls, press releases, physician notifications and social media postings, as well as informing the FDA and other regulators of the actions.
  • Source